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Background: China is undergoing a rapid transition to an urbanized andWestern diet pattern, whichworsens the
public health burden of metabolic syndrome (MS) and chronic kidney disease (CKD). We aimed to estimate the
prevalence of CKD among adults with MS and to evaluate the association between MS and CKD in China.
Methods: The data were obtained from the China National Diabetes and Metabolic Disorders Study conducted
from June 2007 toMay 2008. A total of 15,987 individuals aged 20 y or olderwere included as study participants.
Results: Age-standardized prevalence of CKD, which was deﬁned as a glomerular ﬁltration rate b60 ml/min/
1.73 m2, in participants with and without MS was 4.64% and 3.30%, respectively. The multivariate-adjusted
odds ratio of CKD associatedwith MSwas 1.495 (95% CI: 1.190–1.879). Elevated blood pressure, elevated fasting
glucose, elevated triglycerides, and reduced high-density lipoprotein cholesterol had statistically signiﬁcant in-
creased odds ratios of 1.218, 1.256, 1.325 and 1.797 for CKD, respectively, while elevated waist circumference
was not signiﬁcantly associated with an increased odds ratio of CKD.
Conclusions: Our study suggests an increasing prevalence of CKD among Chinese adults with MS and a strong as-
sociation between CKD and MS.© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-SA license.1. Introduction
China's large population has a high prevalence of chronic kidney dis-
ease (CKD) [1,2], which contributes greatly to the increase of cardiovas-
cular disease, end-stage renal disease and kidney transplantation [3].
Metabolic syndrome (MS), which is characterized as a cluster of meta-
bolic abnormalities including obesity, hyperglycemia, hypertensionology, Xijing Hospital, Fourth
n 710032, China. Tel./fax: +86
nology, China-Japan Friendship
6.
), jqiuhe@fmmu.edu.cn (Q. Ji).
olic Disorders Study Group are
. Open access under CC BY-NC-SA licand dyslipidemia [4], shares many risk factors with CKD [5,6]. During
the past decade, the association of MS with CKD has been emerging
[5]. According to Yi-Jing Sheen's review, the association between MS
and CKD in different populations varies with odds ratio (OR) ranging
from0.93 to 2.60 [6]. Of dozens of studies onMS andCKD, an insufﬁcient
number involves epidemiologic studies focusing on the Chinese popula-
tion. To the best our knowledge, there have been less than ten studies to
date [7–13], and most of these were regional or involved a single prov-
ince [7–12]. The most recent nationwide study was reported by Chen,
who analyzed the data from the International Collaborative Study of
Cardiovascular Disease in Asia (InterASIA) study conducted during
2000 to 2001 [13]. In the past decade, China is undergoing a rapid tran-
sition to an urbanized andWestern diet pattern, including high-protein
food intake [14], which worsens the public health burden of MS and
CKD. Therefore, our knowledge needs to be updated.
Given this background, we utilized the data from the 2007–08 China
National Diabetes andMetabolic Disorders Study; we aimed to estimate
the prevalence of CKD among adults with MS and to evaluate the asso-
ciation between MS and CKD in Chinese adults.ense.
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2.1. Study population
The 2007–08 China National Diabetes and Metabolic Disorders
Study was a nationwide population-based cross-sectional survey,
conducted from June 2007 to May 2008. The details of the study
have been described elsewhere [15]. In brief, a multi-stage stratiﬁed
samplingmethod was used to select a nationally representative sample
of Chinese adults aged N20 y. A total of 17 study group ﬁeld centers par-
ticipated in the study, and 54,240 individuals from the general popula-
tion were selected and invited. Of those individuals, 87.3% (47,325
individuals: 18,976 men and 28,349 women) participated, and 85.2%
(46,239 individuals: 18,419 men and 27,820 women) completed the
study. Considering kidney function was not the primary expected out-
come, serum creatinine (SCr) was not measured at all of the centers.
Therefore, we only included 15,987 individuals (6421 men and 9566
women) with complete data on SCr, fasting plasma glucose, systolic
blood pressure, diastolic blood pressure, serum triglyceride level,
serum high-density lipoprotein cholesterol (HDL-c), and waist circum-
ference. The map of inclusive/exclusive centers is shown in Fig. S1.
This study was approved by the institutional review boards from all of
the 17 participating centers. Written informed consent was obtained
from each participant prior to data collection. The 17 institutional re-
view boards' approvals covered every participant in the study.
2.2. Data collection
A standard questionnaire was designed and administered by trained
physicians or nurses to collect information on demographic characteris-
tics, lifestyle risk factors, and personalmedical history. Educational level
was categorized as college level or above, secondary school, and ele-
mentary school or below. Yearly family income was categorized as
b10,000 China Yuan (CNY), 10,000–30,000 CNY and N30,000 CNY. Cig-
arette smokingwas deﬁned as a lifetime history of smoking at least 100
cigarettes. Alcohol drinking was deﬁned as consuming alcohol at least
once per week for ≥1 y. Physical activity was deﬁned as participating
in moderate or vigorous activity for 30 min/day for at least 3 days a
week. Body weight and height were measured without shoes and in
light clothing. Waist circumference was measured at the middle point
between the costal margin and iliac crest. Blood pressure wasmeasured
using a standardized mercury sphygmomanometer in the sitting posi-
tion after at least 5 min of rest; 2 consecutive readings of blood pressure
were taken on the same arm and the mean of the 2 measures was used
for analysis [15].
After at least 10 h of overnight fasting, an oral glucose tolerance test
was performed on all subjects for the measurement of serum glucose
and insulin. Participants with no history of diabetes were administered
a standard 75-g glucose solution,while participantswith a self-reported
history of diabetes were given a steamed bun that contained approxi-
mately 80 g of complex carbohydrates for safety reasons. Fasting
blood samples were also taken to measure serum triglyceride and
HDL-c level. All laboratory measurements met a standardization and
certiﬁcation program [15].
2.3. Deﬁnition of metabolic syndrome and chronic kidney disease
2.3.1. Metabolic syndrome
Metabolic syndromewas deﬁned using the National Cholesterol Ed-
ucation ProgramAdult Treatment Panel III (NECP-ATP-III) criteria as≥3
of the following 5 metabolic components: 1) elevated waist circumfer-
ence: ≥90 cm (males) or ≥80 cm (females); 2) elevated triglycerides:
≥1.69 mmol/l or the use of lipid medications; 3) elevated blood pres-
sure: systolic blood pressure ≥130 mm Hg, or diastolic blood pressure
≥85 mm Hg, or the use of antihypertensive medications; 4) elevatedfasting glucose: ≥5.6 mmol/l or the use of diabetes medications; 5) re-
duced HDL-c: b1.04 mmol/l (male) or b1.29 mmol/l (female) [4].
2.3.2. Deﬁnition of chronic kidney disease
Glomerular ﬁltration rate (GFR) was calculated using the abbreviat-
ed equation developed by the modiﬁcation of diet in renal disease
(MDRD) study with modiﬁcation for the Chinese population [16].
Considering most of our centers measured SCr on a Hitachi analyzer
using the Jaffe's kinetic method, we adopted the following equation:
175 × (SCr × 0.01131) (mmol/l)−1.234 × Age (y)−0.179 × (0.79 if
female), which has been validated in the Chinese population and is
also used by previous studies [9]. Chronic kidney disease (CKD) was de-
ﬁned as a GFR b60 ml/min/1.73 m2 according to the USNational Kidney
Foundation guidelines [17].
2.3.3. Other deﬁnitions
StandardWorld Health Organization criteria were used for the diag-
nosis of diabetes: fasting glucose ≥7.0 mmol/l or 2 hour postprandial
glucose ≥11.1 mmol/l, or self-reported use of diabetes medications
[18]. Hypertension was deﬁned according to the Seventh Report of
the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure: systolic blood pressure of
≥140 mm Hg, diastolic blood pressure of ≥90 mm Hg, or self-
reported use of antihypertensive medications [19].
2.4. Statistical analysis
Data were analyzed using SPSS 18.0 or Stata 11.0 software for Win-
dows. Data were expressed as the mean ± SD, median with interquar-
tile range, or percentage as suitable. Comparisons between groups were
analyzed by t-test or Mann–Whitney U-test for measurement data, and
χ2 test for enumeration data.
Age-standardized prevalence of CKD was compared in populations
with and without MS according to gender. Age-standardized point
prevalence estimates and standard error (SE) stratiﬁed by sexwere cal-
culated using Stata (ver. 11.0) svy commands (direct standardization)
to account for the multi-stage stratiﬁed random sampling design. The
calculation was weighted based on Chinese population data from
2006 [20]. The crude prevalence of CKDwas determined for participants
with andwithout the ﬁve individual components of MS, whichwas also
calculated by the number of the MS components.
Logistic regression analysis was utilized to examine the association
between MS and its components and CKD. Odds ratios (OR) and 95%
conﬁdence intervals (95% CI) were calculated using a forward stepwise
method. The covariables in themultivariate analysis were age (continu-
ous variable), gender, ethnics, educational level, yearly family income,
cigarette smoking, alcohol drinking, and physical activities. Because hy-
pertension and diabetes are the most important established risk factors
for CKD [21], a further adjustment for hypertension and diabetes was
performed in the next step. In particular, we calculated the adjusted
OR after excluding the individuals with diabetes since diabetes popula-
tion do much contribution to CKD.
We conducted a sensitivity analysis between study participants and
the excluded participants to evaluate the relevance because large
amount of individuals dropped out of our analysis. All statistical tests
were 2 sided. P b 0.05 was considered statistically signiﬁcant.
3. Results
The clinical characteristics of the study participants are shown in
Table 1. Of a total of 15,987 participants, 4749 had MS. On average, par-
ticipants withMSwere older, more likely to be Han, had a relatively low
level of education and a high level of yearly family income compared
with their participants without MS. The mean level of serum creatinine
was signiﬁcantly higher among the participants with MS compared
with those without MS.
Table 1
Demographics, lifestyle risk factors, and clinical characteristics of the study participants with and without metabolic syndrome.
Variable All participants Participants with MS Participants without MS P value
N 15,987 4749 11,238
Age, y 46.4 ± 13.8 52.6 ± 12.2 43.7 ± 13.7 b0.001
Gender (men), n (%) 6421 (40.2) 1935 (40.7) 4486 (39.9) NS
Ethnics (Han), n (%) 15,436 (97.7) 4614 (98.3) 10,822 (97.5) 0.003
Educational level, n (%) b0.001
Elementary school or below 3013 (19.1) 1197 (25.6) 1816 (16.4)
Secondary school 9497 (60.2) 2815 (60.2) 6682 (60.2)
College or above 3256 (20.7) 663 (14.2) 2593 (23.4)
Yearly family income, n (%) (n = 15,046) (n = 4492) (n = 10,554) 0.025
≤10,000 CNY 4936 (32.8) 1402 (31.2) 3534 (33.5)
10,000–30,000 CNY 6247 (41.5) 1913 (42.6) 4334 (41.1)
N30,000 CNY 3863 (25.7) 1177 (26.2) 2686 (25.5)
Cigarette smoking, n (%) 3685 (23.1) 1107 (23.4) 2578 (23.0) NS
Alcohol drinking, n (%) 3579 (22.5) 1048 (22.2) 2531 (22.6) NS
Physical activities, n (%) 7430 (46.6) 2330 (49.3) 5100 (45.5) b0.001
Waist circumference, cm 81.9 ± 11.0 90.5 ± 8.8 78.3 ± 9.8 b0.001
Body mass index, kg/m2 24.3 ± 3.8 27.1 ± 3.4 23.2 ± 3.3 b0.001
Systolic blood pressure, mm Hg 122.3 ± 19.5 134.7 ± 18.9 117.1 ± 17.2 b0.001
Diastolic blood pressure, mm Hg 77.5 ± 11.2 83.6 ± 11.2 75.0 ± 10.1 b0.001
Serum glucose level, mmol/l 5.4 ± 1.4 6.2 ± 1.9 5.1 ± 1.0 b0.001
Serum triglyceride level, mmol/l 1.6 ± 1.2 2.5 ± 1.5 1.2 ± 0.7 b0.001
Serum HDL-c level, mmol/l 1.4 ± 0.3 1.2 ± 0.3 1.4 ± 0.3 b0.001
Serum creatinine level, μmol/l 72.8 ± 20.1 73.5 ± 21.2 72.1 ± 19.6 0.006
GFR, ml/min per 1.73 m2 100.5 (80.4–126.8) 99.0 (78.5–124.4) 102.1 (82.7–128.6) b0.001
Abbreviations: MS, metabolic syndrome; CNY, China Yuan; HDL-c, high-density lipoprotein cholesterol; GFR, glomerular ﬁltration rate.
Formula: GFR: 175 × (SCr × 0.01131) (mmol/l)−1.234 × Age (y)−0.179 × (0.79 if female).
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signiﬁcantly higher formales, females andmales and females combined
compared with those without MS (4.90% vs. 2.24%, 6.78% vs. 5.78%, and
4.64% vs. 3.30%, respectively, P b 0.001). (Table 2) Elevated blood pres-
sure, increased fasting glucose, increased triglycerides, reduced serum
HDL-c, and elevatedwaist circumference were all signiﬁcantly associat-
ed with an increased prevalence of CKD. Furthermore, a signiﬁcantly
graded relationship was shown between the number of components
and the corresponding prevalence of CKD (Table 3).Table 2
Age-standardized prevalence of chronic kidney disease in metabolic syndrome according to ge
Age group, y All participants Participants wit
n/N % ± SE n/N
Male
20–30 4/933 0.4 ± 0.4 2/116
30–40 12/1220 1.0 ± 0.5 7/333
40–50 16/1548 1.0 ± 0.5 7/511
50–60 44/1423 3.1 ± 0.9 23/491
≥60 82/1297 6.3 ± 1.3 41/484
Crude 158/6421 2.5 ± 0.4 80/1935
Standardized 3.14 ± 0.49
Female
20–30 19/1256 1.5 ± 0.7 1/55
30–40 42/1961 2.1 ± 0.7 5/261
40–50 74/2393 3.1 ± 0.7 26/589
50–60 115/2291 5.0 ± 0.9 55/983
≥60 167/1665 10.0 ± 1.5 96/926
Crude 417/9566 4.4 ± 0.4 183/2814
Standardized 6.13 ± 0.58
Total
20–30 23/2189 1.1 ± 0.4 3/171
30–40 54/3181 1.7 ± 0.4 12/594
40–50 90/3941 2.3 ± 0.5 33/1100
50–60 159/3714 4.3 ± 0.6 78/1474
≥60 249/2962 8.4 ± 1.0 137/1410
Crude 575/15,987 3.6 ± 0.3 263/4749
Standardized 3.77 ± 0.31
Abbreviations: SE, standard error. The calculations were weighted on the basis of Chinese popuCrude and multivariate-adjusted odds ratios of CKD associated with
MS and its components are presented in Table 4. In the multivariate
models, elevated blood pressure, elevated fasting glucose, elevated
triglycerides level, and reduced HDL-c had a statistically signiﬁcant in-
creased odds ratios of 1.218, 1.256, 1.325 and 1.797 for CKD, respective-
ly, while elevated waist circumference was not signiﬁcantly associated
with an increased odds ratio of CKD. Participants with 3, 4, and 5 com-
ponents of MS had 1.489, 1.618, and 2.327 fold signiﬁcantly increased
odds of CKD, respectively, compared with those with 0 components.nder.
h MS Participants without MS P value
% ± SE n/N % ± SE
1.7 ± 2.4 2/817 0.2 ± 0.4
2.1 ± 1.6 5/887 0.6 ± 0.5
1.4 ± 1.0 9/1037 0.9 ± 0.5
4.7 ± 1.9 21/932 2.3 ± 1.0
8.5 ± 2.5 41/813 5.0 ± 1.5
4.1 ± 0.9 78/4486 1.7 ± 0.3
4.90 ± 1.16 2.24 ± 0.39 b0.001
1.8 ± 3.7 18/1201 1.5 ± 0.7
1.9 ± 1.7 37/1700 2.2 ± 0.8
4.4 ± 1.6 48/1804 2.7 ± 0.7
5.6 ± 1.4 60/1308 4.6 ± 1.1
10.4 ± 1.9 71/739 9.6 ± 2.1
6.5 ± 0.9 234/6752 3.5 ± 0.4
6.78 ± 1.39 5.78 ± 0.75 b0.001
1.8 ± 1.9 20/2018 1.0 ± 0.4
2.0 ± 1.2 42/2587 1.6 ± 0.5
3.0 ± 1.0 57/2841 2.0 ± 0.5
5.3 ± 1.1 81/2240 3.6 ± 0.8
9.7 ± 1.6 112/1552 7.2 ± 1.3
5.5 ± 0.7 312/11,238 2.8 ± 0.3
4.64 ± 0.70 3.30 ± 0.36 b0.001
lation data from 2006; Chronic kidney disease was deﬁned as a GFR b60 ml/min/1.73 m2.
Table 3
Crude-prevalence of chronic kidney disease among participants with andwithout compo-
nent of metabolic syndrome.
Component n/N Prevalence ± SE P value
Raised blood pressure b0.001
Yes 329/6651 4.9 ± 0.5
No 246/9336 2.6 ± 0.3
Raised serum glucose b0.001
Yes 212/4248 5.0 ± 0.7
No 363/11,739 3.1 ± 0.3
Raised serum triglycerides b0.001
Yes 235/4991 4.7 ± 0.6
No 340/10,996 3.1 ± 0.3
Lowered serum HDL-c b0.001
Yes 267/5179 5.2 ± 0.6
No 308/10,808 2.8 ± 0.3
Larger waist circumference b0.001
Yes 290/6807 4.3 ± 0.4
No 285/9180 3.1 ± 0.4
Number of components b0.001
0 70/3699 1.9 ± 0.4
1 114/4053 2.8 ± 0.5
2 128/3486 3.7 ± 0.6
3 131/2663 4.9 ± 0.8
4 90/1568 5.7 ± 0.8
5 42/518 8.1 ± 2.4
Abbreviations: HDL-c, high-density lipoprotein cholesterol; SE, standard error. Chronic
kidney disease was deﬁned as a GFR b60 ml/min/1.73 m2.
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After adjustments for age, gender, ethnics, educational level, yearly fam-
ily income, cigarette smoking, alcohol drinking, and physical activities,
the odds ratio was 1.495 (95% CI: 1.190–1.879). After further adjust-
ment for hypertension and diabetes, signiﬁcance still persisted with
an odds ratio of 1.462 (95% CI: 1.147–1.864). Additionally, among par-
ticipants without diabetes the same signiﬁcant association between
MS and CKD was observed (OR: 1.321, 95% CI: 1.075–1.622).
Table S1 shows the comparison of the clinical characteristics be-
tween study and drop-out participants to evaluate the relevance. The
results showed no signiﬁcant difference with the proportion of gender,
waist circumference, systolic blood pressure, or serum glucose. Howev-
er, the study participants were older compared with the drop-out par-
ticipants, and there were signiﬁcant differences with other metabolic
variables including bodymass index, diastolic blood pressure, serum tri-
glyceride level and serum HDL-c level.Table 4
Crude and multivariate-adjusted odds ratio of chronic kidney disease associated with metabol
Variable Odds ratio of chronic kidney disease (95% CI)
Crudea x2
Elevated blood pressure 1.934 (1.625–2.302) 55.085
Increased fasting glucose 1.686 (1.410–2.017) 37.764
Increased triglycerides 1.555 (1.305–1.854) 34.706
Reduced HDL-c 1.918 (1.614–2.281) 54.480
Elevated waist circumference 1.370 (1.153–1.628) 12.803
Number of componentc
1 1.525 (1.117–2.082) 7.061
2 1.912 (1.405–2.600) 17.043
3 2.629 (1.935–3.572) 38.217
4 3.203 (2.307–4.447) 69.716
5 4.977 (3.334–7.432) 61.572
Metabolic syndrome
Model 1 (n = 15987) 2.019 (1.626–2.507) 40.489
Model 2d (n = 15987)
Model 3e (n = 14297)
a Unadjusted.
b Adjusted for age (continuous variable), gender, ethnics, educational level, yearly family in
c Number zero of component as ref.
d Further adjusted for hypertension and diabetes.
e Individuals with diabetes excluded.4. Discussion
Since a report on the data from the InterASIA study [13], there were
no new nationwide reports that evaluated the association between MS
and CKD in China. The present paper, utilizing the data from the
2007–08 China National Diabetes and Metabolic Disorders Study, esti-
mated an increasing age-standardized prevalence of CKD (4.64%), de-
ﬁned as a GFR b60 ml/min/1.73 m2, in the MS population. The results
also showed that Chinese adults with MS had a 50% increase in the
odds of CKD compared with individuals without MS.
In the present study, the age-standardized prevalence of CKD in par-
ticipants withMSwas 4.64%, whichwas higher than that in another na-
tionwide report (3.3%) on the data from the InterASIA study [13]. Some
possibilities may contribute to the difference, including the age of the
participants, the parameters of HDL-c in the MS criteria, and the differ-
ent equation used to calculate estimated GFR. Apart from the above ex-
planations, we speculated that the prevalence of CKD in participants
with MS was increasing over the past decade in China due to the in-
creasing incidence of obesity and type 2 diabetes coupled with an
aging population [3].
This study showed that MS was signiﬁcantly associated with CKD
and that Chinese adults with MS had a 50% increased odds of CKD com-
pared with individuals without MS. Diabetes and hypertension are the
most important well-established risk factors for CKD [21]. In the multi-
variable analysis,we further adjusted for diabetes and hypertension and
found that signiﬁcance still persisted with an odds ratio of 1.462 (95%
CI: 1.147–1.864), indicating that the association between MS and CKD
was independent of diabetes and hypertension. Several epidemiological
studies have documented a relationship between MS and CKD
[7–9,11–13,22–37]. For example, Chen et al. analyzed data from the
Third National Health and Nutrition Examination Survey and showed
thatMSmight be an important factor in the etiology of CKD [37]. Kurella
et al. followed a total of 10,096 nondiabetic participants for 9 y and
found that MS was independently associated with an increased risk
for CKD in nondiabetic adults [36]. In China, Chen et al. reported the
multivariate-adjusted OR of CKD in participants with MS compared to
those without was 1.64 (95% CI: 1.16–2.32) by using the data from the
InterASIA study during 2000–2001 [13]. Zhang et al. performed a
cross-sectional survey that included 2310 participants (age ≥ 40 y)
fromBeijing in 2004 andobserved strongunadjusted and adjusted asso-
ciations between MS and CKD [11]. All of the above studies consistent
with our study conﬁrmed a strong relationship between MS and CKD.ic syndrome and its components.
P value Multivariate-adjustedb x2 P value
b0.001 1.218 (1.005–1.474) 4.061 0.044
b0.001 1.256 (1.043–1.512) 5.806 0.016
b0.001 1.325 (1.106–1.586) 9.367 0.002
b0.001 1.797 (1.504–2.146) 41.693 b0.001
b0.001 0.856 (0.713–1.029) 2.740 NS
0.008 1.176 (0.857–1.613) 1.008 NS
b0.001 1.209 (0.880–1.660) 1.367 NS
b0.001 1.489 (1.080–2.053) 5.918 0.015
b0.001 1.618 (1.145–2.286) 7.444 0.006
b0.001 2.327 (1.530–2.599) 15.583 b0.001
b0.001 1.495 (1.190–1.879) 13.935 b0.001
1.462 (1.147–1.864) 9.387 0.002
1.321 (1.075–1.622) 7.026 0.008
come, cigarette smoking, alcohol drinking, and physical activities.
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the Chinese population is inconclusive. In our study, multivariate-
adjusted analysis showed that elevated waist circumference was not
signiﬁcantly associated with CKD (OR: 0.856, 95% CI: 0.713–1.029,
P = 0.098), which was consistent with the ﬁndings from Zhang et al.
[11] and Jiang et al. [9] but opposite to the results from the report
by Chen et al. [13]. The remaining four individual components were in-
dependent risk factors for CKD in our study, but Chen et al. [13] reported
that elevated blood pressure, elevated triglycerides, and reduced HDL-c
were not signiﬁcantly associated with CKD. Similarly, reduced HDL-c in
Zhang's study [11], increased serum triglycerides concentration in the
Jiang et al. [9] and Liu et al. [38] studies, and reduced HDL-c in the
Jiang et al. study [9] were not signiﬁcant determinants of CKD. The dis-
crepancy might be partly due to differences in the deﬁnitions used for
MS, the equation used to calculate estimated GFR, and the demographic
characteristics of the included study participants. For example, Chen
et al. [13] included participants aged 35–70 y and used an original
equation for estimated GFR. Zhang et al. [11] examined an elder popula-
tion with age N40 y and Jiang et al. [9] studied the association between
MS and CKD in a rural Chinese population. Liu et al. [38] recruited par-
ticipants aged N45 y and the cutoff of hypertriglyceridemia was
2.26 mmol/l. However, similar to the other three studies, we identiﬁed
a graded relationship between the number of components and the cor-
responding prevalence of CKD.
Although the 2007–08 ChinaNational Diabetes andMetabolic Disor-
ders Study was a well-designed population-based survey, some limita-
tions should be mentioned. Firstly, the association in the present
paper, as with any observational study, did not imply certain causality.
Secondly, GFR was not directly measured but instead was calculated
with an estimated creatinine-based equation. However, the following
two reasons may offset the bias to some extent: (a) these methodolo-
gies are complex and not feasible in a large population-based epidemi-
ologic study; (b) themodiﬁedMDRD equationwe adopted shows lower
bias and higher accuracy in each stage of CKD when applied to Chinese
populations, particularly in patients with near-normal kidney function
[16]. Finally, a large number of participants without serum creatinine
measurement were excluded. Because these individuals showed signif-
icant difference in age, ethnicity and somemetabolic variables based on
the sensitivity analysis shown in Table S1, exclusion of these individuals
would be expected to bias the study results toward the null.
In summary, the present paper, which used a nationwide represen-
tative sample, estimates an increasing prevalence of CKD in Chinese
adults with MS. The results also indicate a strong association between
CKD and MS. With the increasing number of patients with MS in
China [39], the burden of CKD needsmore effective control and preven-
tion strategies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cca.2014.01.004.
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